MIRAE ASSET
HEALTHCARE FUND - (MAHCF)

(Sectoral/Thematic Fund - An open ended equity scheme investing in healthcare and allied sectors)
Details as on April 30, 2023
Type of Scheme Sectoral/Thematic Fund - An open ended equity scheme investing in healthcare and allied sectors
Investment Objective The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India. The Scheme does not guarantee or assure any returns.
Fund Manager**
Mr. Vrijesh Kasera
(since July 02, 2018)
Allotment Date 02nd July, 2018
Benchmark Index S&P BSE Healthcare Index (TRI)
Minimum Investment
Amount
₹ 5,000/- and in multiples of ₹ 1/-thereafter. Minimum Additional Application Amount: ₹ 1,000/- per application and in multiples of ₹ 1/- thereafter.
Systematic Investment
Plan (SIP)
(Any Date SIP is available from 1st July, 2019)
Monthly and Quarterly: ₹ 1,000/- (multiples of ₹ 1/- thereafter), minimum 5 in case of Monthly or 3 in case of Quarterly option.
Load Structure Entry load: NA
Exit load:
I. For investors who have opted for SWP under the plan:
a) 15% of the units allotted (including Switch-in/STP - in) on or before completion of 365 days from the date of allotment of units: Nil.
b) Any redemption in excess of such limits in the first 365 days from the date of allotment shall be subject to the following exit load: (Redemption of units would be done on First In First Out Basis (FIFO):
•If redeemed within 1 year (365 days) from the date of allotment: 1%
•If redeemed after 1 year (365 days) from the date of allotment: NIL
II. Other Redemptions: For Investors who have not opted for SWP under the plan (including Switch out, STP out):
•If redeemed within 1 year (365 days) from the date of allotment: 1%
•If redeemed after 1 year (365 days) from the date of allotment: NIL
Plans Available Regular Plan and Direct Plan
Options Available Growth Option and IDCW Option (Payout & Re-investment)
Monthly Average AUM
(₹ Cr.) as on April 30, 2023
1,555.32
Net AUM (₹ Cr.) 1,583.14
Monthly Avg. Expense Ratio
(Including Statutory Levies)
as on April 30, 2023
Regular Plan: 2.07%
Direct Plan: 0.55%
**For experience of Fund Managers Click Here
NAV: Direct Regular
Growth ₹ 22.789 ₹ 21.117
IDCW ₹ 17.611 ₹ 15.940
Positions Increased
Stock
Healthcare Services
Syngene International Limited
Pharmaceuticals & Biotechnology
Biocon Limited
Cipla Limited
Positions Decreased
Stock
Pharmaceuticals & Biotechnology
Ajanta Pharma Limited
Dr. Reddy's Laboratories Limited
IPCA Laboratories Limited

Portfolio Holdings % Allocation
Pharmaceuticals & Biotechnology
Sun Pharmaceutical Industries Ltd
18.19%
Cipla Limited
8.83%
Dr. Reddy's Laboratories Ltd
8.12%
Torrent Pharmaceuticals Ltd
6.97%
Aurobindo Pharma Ltd
5.36%
JB Chemicals & Pharmaceuticals Limited
5.30%
Ajanta Pharma Ltd
3.68%
Biocon Ltd
2.99%
Divi's Laboratories Ltd
2.77%
Lupin Limited
2.09%
Gland Pharma Limited
2.08%
Alkem Laboratories Limited
2.01%
Natco Pharma Limited
1.24%
IPCA Laboratories Limited
0.92%
Abbott India Limited
0.00%
Sanofi India Limited
0.00%
Healthcare Services
Apollo Hospitals Enterprise Limited
8.48%
Krishna Institute Of Medical Sciences Limited
6.36%
Fortis Healthcare Limited
3.03%
Syngene International Limited
1.06%
Dr. Lal Path Labs Limited
0.00%
Insurance
SBI Life Insurance Company Limited
1.36%
ICICI Lombard General Insurance Company Limited
1.33%
Max Financial Services Ltd
1.22%
Chemicals & Petrochemicals
Vinati Organics Ltd
2.05%
Tatva Chintan Pharma Chem Limited
1.60%
Healthcare Equipment & Supplies
Tarsons Products Limited
1.29%
Equity Holding Total
98.33%
Cash & Other Receivables
1.67%
Total
100.00%

Growth of Rs. 10,000 invested at inception: 21,117

Returns (in%)
1 Yr 3 Yrs SI
MAHCF
-4.38%
16.52%
16.76%
Scheme Benchmark*
-4.67%
15.26%
11.74%
Additional Benchmark**
8.48%
23.36%
13.34%
NAV as on 28th April, 2023 ₹ 21.117
Index Value (28th April, 2023) Index Value of Scheme benchmark is 26,300.48 and S&P BSE Sensex (TRI) is 92,568.15
Allotment Date 02nd July, 2018
Scheme Benchmark *S&P BSE Healthcare Index (TRI)
Additional Benchmark **S&P BSE Sensex (TRI)

Fund manager : Mr. Vrijesh Kasera managing the scheme since July 02, 2018
Note: Returns below or for 1 year are absolute returns, returns above 1 year are CAGR- Compounded Annualized Growth returns.

Past Performance may or may not be sustained in future. Note : For computation of since inception returns (%) the allotment NAV has been taken as ₹ 10.00. The performance of other funds managed by the same fund manager is given in the respective page of the schemes
Different Plans under the scheme has different expense structure. The reference and details provided here in are of Regular Plan - Growth Option

Period Total Amount Invested Mkt Value as on
28-April-2023
SI
570,000
807,939
3 Yr
360,000
386,360
1 Yr
120,000
119,766

Returns (%)
Period
SI
3yr
1yr
Fund Return& (%)
14.76
4.67
-0.37
Benchmark Return& (%)
11.28
3.88
2.19
Add. Benchmark Return& (%)
14.60
14.61
9.63

& The SIP returns are calculated by XIRR approach assuming investment of ₹ 10,000/- on the 1st working day of every month.

Volatility 16.08%
Beta: 0.96
R Squared 0.96
Sharpe Ratio#: 0.60
Information Ratio 0.40
Portfolio Turnover Ratio 0.15 times

@The Volatility, Beta, R Squared, Sharpe Ratio & Information Ratio are calculated on returns from last three years Monthly data points. # Risk free rate: FBIL OVERNIGHT MIBOR as on 30th April, 2023.^Basis last rolling 12 months.

This product is suitable for investors who are seeking*
• To generate long term capital appreciation
• Investments in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sector in India

*Investors should consult their financial advisers if they are not clear about the suitability of the product.

Record Date IDCW (₹) Face Value ( ₹) Cum Nav ( ₹)
22-Mar-22
1.80 per Unit
10
22.196
14-Feb-23
1.70 per Unit
10
17.295

Past Performance may or may not be sustained in future. Pursuant to payment of IDCW the NAV of the IDCW option of the scheme will fall to the extent of payout and statutory levy (if any). IDCW history is for MAHCF - Regular Plan - IDCW Option